I tend to be leucopenic even when not on rapa. My last result was 980 n vs 830 l. I think my protocol soups up short transcripts and i dont take any exogenous peptides.
I did 1.67 mg on three consecutive days. Can hardly get better results, but still ask do you think there is any advantage in spacing it more?
In clinical use, TA-1 is often dosed every day for months but that is for immune compromised individuals.
I’d do a more conservative approach like you are doing, 3 to 4 doses a week for 4 weeks and then test.
How long is the improvement expected to last? Can TA-1 be taken for a month every N months?
I also don’t gave an optimal NLR and do everything positive mentioned in this topic. ChatGPT suggested low-dose naltrexone, so I started 2mg/day 2 weeks ago. This is a good article about LDN for autoimmunity;
My neutrophil-to-lymphocyte ratio went down:
2.62/1.43 = 1.832 (March 10)
2.68/2.17 = 1.235. (Apr 14). Now worry it’s too low.
It could be bc of medication change: replaced Labetalol by Nebivolol, changed to Rapamycin 1 mg/week. Positives: feel overall better, occasional face puffiness is completely gone, some skin spots became lighter, skin in general improved much. Negatives: very slight occasional headache, lower HR (49 daytime and 38 sleep).
I’m going to throw some chit at the wall I’m going to use my engineering logic on this one. Which is probably different from a bio-science person with expertise in this area. So here goes…
- TA-1 is one of the 3 hormones the Thymus produces that maturate T-cells.
- The Thymus eventually stops producing all the hormones that maturate T-cells (Thymic involution)
- T-cells continue to be produced over our life span in an non-maturated condition
- T-cells produced during Thymic involution may not be properly or fully maturated?
- T-cells produced when Thymic involution is inevitably complete, are not maturated at all.
- There are 4 main groups of T-cells with variances within those groups
- Each T-cell type has different half-lives
My “if > then” statement
As Thymosin A1 is a key “maturator”
If - T-cells become maturated by exogenous use of TA-1
Then - the effect of exogenous TA-1 on any T-cell that gets maturated should last for the life of that T-cell as it does for those maturated during the functional life of the rapidly involuting Thymus.
How long do naive T cells live and how are they replenished? A short life span for naive T cells would necessitate faster rates of replenishment, whereas in- creased life span would accommodate slower rates of replenishment. Work in this issue of Immunity by den Braber et al. (2012) examines the longevity of naive T cells. Their data suggest that mechanisms maintaining T cells with naive phenotypes might differ in humans and mice
And that is why I also use LL 37 when I’m working on my short term immune failures.
Posted this a while ago, my understanding is you want to be close to 1?
N = Neutrophil (innate) L = lymphocytes (acquired and innate)
Rapamycin mainly affect Neutrophil (?) @DrFraser
As to NLR , my understanding per Gork is you want your L higher than R but the ratio between 0.78-3.5 is considered normal.
And FWIW, my own blood works has shown little change in lymphocytes over the course of rapamycin, but my neutrophil to some degree is a function of rapamycin dose (suppressed lower but still normal). Hence, I monitor the trend and ratio of my NLR as a way to gauge my rapamycin dosing.
I agree - I think the major impact of Rapamycin is a decreased neutrophil count, and with that, you’ll improve ratio. I’ve seen some people have a little rise in lymphocytes, but not consistently. My average Rapamycin patient has a total WBC of around 3.5.
AIUI because neutrophils have a short half life intermittent rapamycin hits them quickly